Role of the FDA in affordability of off-patent pharmaceuticals

Jeremy A. Greene; Gerard Anderson; Joshua M. Sharfstein

doi:10.1001/jama.2015.18720

Role of the FDA in affordability of off-patent pharmaceuticals

Jeremy A. Greene, Gerard Anderson, Joshua M. Sharfstein

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	461-462
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	315
Issue number	5
DOIs	https://doi.org/10.1001/jama.2015.18720
State	Published - Feb 2 2016

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2015.18720

Cite this

@article{6a1542897b184875b612159c6368822a,

title = "Role of the FDA in affordability of off-patent pharmaceuticals",

author = "Greene, {Jeremy A.} and Gerard Anderson and Sharfstein, {Joshua M.}",

year = "2016",

month = feb,

day = "2",

doi = "10.1001/jama.2015.18720",

language = "English (US)",

volume = "315",

pages = "461--462",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Role of the FDA in affordability of off-patent pharmaceuticals

AU - Greene, Jeremy A.

AU - Anderson, Gerard

AU - Sharfstein, Joshua M.

PY - 2016/2/2

Y1 - 2016/2/2

UR - http://www.scopus.com/inward/record.url?scp=84957793312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957793312&partnerID=8YFLogxK

U2 - 10.1001/jama.2015.18720

DO - 10.1001/jama.2015.18720

M3 - Short survey

C2 - 26747694

AN - SCOPUS:84957793312

SN - 0098-7484

VL - 315

SP - 461

EP - 462

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 5

ER -

Role of the FDA in affordability of off-patent pharmaceuticals

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this